The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Similar exposure and pharmacokinetics of bevacizumab in pediatric and adult cancer patients: Analysis of individual data of 152 pediatric patients.
Kelong Han
No relevant relationships to disclose
Thomas Peyret
No relevant relationships to disclose
Nathalie H. Gosselin
No relevant relationships to disclose
Angelica Linnea Quartino
No relevant relationships to disclose
Sridharan Gururangan
No relevant relationships to disclose
Clinton F. Stewart
No relevant relationships to disclose
Fariba Navid
No relevant relationships to disclose
Mohamad-Samer Mouksassi
No relevant relationships to disclose
Jin Jin
No relevant relationships to disclose
David E. Allison
No relevant relationships to disclose